scieee Science in your language
[en] (orig)

RETROSPECTIVE ANALYSIS OF THE VARIATIVITY OF SUPPLY OF THE MOST DEMANDED ANTIBIOTICS IN THE TERRITORY OF THE REPUBLIC OF UZBEKISTAN

Author: Azimova N.A; Rakhimov A.A
Publisher: Zenodo
DOI: 10.5281/zenodo.17332627
Source: https://zenodo.org/records/17332627/files/MPHAPP121.pdf
186
Volume 5, Issue 10: Special Issue
(EJAR)
ISSN: 2181-2020
MPHAPP
THE 6TH INTERNATIONAL SCIENTIFIC AND PRACTICAL
CONFERENCE “MODERN PHARMACEUTICS: ACTUAL
PROBLEMS AND PROSPECTS”
TASHKENT, OCTOBER 17, 2025
in-academy.uz
RETROSPECTIVE ANALYSIS OF THE VARIATIVITY OF SUPPLY OF THE MOST
DEMANDED ANTIBIOTICS IN THE TERRITORY OF THE REPUBLIC OF
UZBEKISTAN
Azimo a N.A.
Rakhimo A.A.
Pha maceu ical Ins i u e o Educa ion and Resea ch, Tashken ci y, Republic o Uzbekis an
e-mail: [email p o ec ed]
h ps://doi.o g/10.5281/zenodo.17332627
Rele ance: Analysis o supply s abili y assesses he eliabili y and p edic abili y o logis ical
p ocesses by measu ing indica o s such as ailu e equency, deli e y imes, and se ice quali y o
ensu e imely deli e y o goods and minimize isks. The pha maceu ical indus y is mo e dependen
han e e on he s abili y o d ug supplies, as i di ec ly a ec s human li es. Today, he g oup o
an ibio ic d ugs emains one o he mos in-demand d ugs in domes ic condi ions. In his ega d, we
decided o e ospec i ely analyze how s able he supply o he sough -a e g oup o d ugs is in he
e i o y o he Republic o Uzbekis an.
The pu pose o he s udy: is o analyze he s abili y o he supply o he mos in-demand
an ibio ics in he e i o y o he Republic o Uzbekis an using he coe icien o a ia ion.
Ma e ials and me hods: "D ug-Audi " mon hly summa y da a on he supply o he mos in-
demand an ibio ics o 2018-2022 we e used as esea ch ma e ial. The demand c i e ion was he
s abili y o supplies h oughou he s udied pe iod and he ela i e ad an ageous ma ke sha e o e
he pe iods compa ed o he emaining an ibio ics. As a me hod, a p e iously es ed a ia ion
coe icien me hodology was used, whe e o each deli e y by mon h in indi idual yea s and o each
in e na ional non-pa en ed name o an ibio ics (INN) in packaging, he a ia ion o deli e y was
calcula ed acco ding o he o mula.
Resul s: he main gene alized esul s a e p esen ed in he able. Acco ding o ecei ed he
esul s showed ha o e all, he en i e domes ic ma ke segmen o an ibio ics demons a ed ela i e
s abili y in supply.
The mos s able yea was 2019, when he coe icien o a ia ion dec eased o 19% and by he
end o he s udy pe iod (2022), his indica o eached 23%. Also, among he s udied sample o
187
Volume 5, Issue 10: Special Issue
(EJAR)
ISSN: 2181-2020
MPHAPP
THE 6TH INTERNATIONAL SCIENTIFIC AND PRACTICAL
CONFERENCE “MODERN PHARMACEUTICS: ACTUAL
PROBLEMS AND PROSPECTS”
TASHKENT, OCTOBER 17, 2025
in-academy.uz
an ibio ics acco ding o INN, he mos s able we e "Ce iaxone," "Ce iaxone + Tazobac am,"
"Ce iaxone + Sulbac am," "Cip o loxacin," "Cip o loxacin + Tinidazole," "Cip o loxacin +
O nidazole," and "Me onazole," "Me onazole + Myconazole."
Conclusions: The domes ic ma ke segmen o an ibio ics is gene ally s able in e ms o
supplies, and de iciency phenomena a e no cha ac e is ic o his g oup, excep o indi idual
an ibio ics acco ding o INN.